Involved free light chain: an early independent predictor of response and progression in multiple myeloma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Involved free light chain: an early independent predictor of response and progression in multiple myeloma

Published:2021-04-02 Issue:9 Volume:62 Page:2227-2234
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Gran Charlotte¹²^ORCID,Afram Gabriel¹³,Liwing Johan¹,Verhoek Andre⁴,Nahi Hareth¹³

Affiliation:

1. Department of Medicine, Karolinska Institutet, Stockholm, Sweden

2. Department of Clinical Chemistry, Karolinska University Laboratory, Stockholm, Sweden

3. Haematology Center, Karolinska University Hospital, Stockholm, Sweden

4. Ingress-Health Nederland BV, Rotterdam, The Netherlands

Funder

Cancerfonden

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2021.1907370

Reference18 articles.

1. Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group

2. International Staging System for Multiple Myeloma

3. Role of MRD status in relation to clinical outcomes in newly diagnosed multiple myeloma patients: a meta-analysis

4. The protection receptor for IgG catabolism is the beta2-microglobulin-containing neonatal intestinal transport receptor.

5. Serum free light chains for monitoring multiple myeloma

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Response-Adapted Therapy for Newly Diagnosed Multiple Myeloma;Current Hematologic Malignancy Reports;2023-07-04

2. The Clinical Significance of Serum Free Light Chains in Bladder Cancer;Journal of Clinical Medicine;2023-05-05

3. Efficacy Evaluation of Inflammatory Mediators in the Treatment of Multiple Myeloma with Daratumumab;Journal of Oncology;2022-08-27

4. Prognostic Impact of Serum Free Light Chain Ratio Normalization in Patients with Multiple Myeloma Treated within the GMMG-MM5 Trial;Cancers;2021-09-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3